Literature DB >> 19719750

Cellular calcium regulatory machinery of vasorelaxation elicited by petasin.

Guei-Jane Wang1, Yun-Lian Lin, Chu-Huang Chen, Xi-Chen Wu, Jyh-Fei Liao, Jun Ren.   

Abstract

1. The present study examined the cytosolic Ca(2+) regulatory machinery involved in the vasorelaxation produced by petasin, a sesquiterpene isolated from Petasites formosanus. 2. Aortic rings isolated from Sprague-Dawley rats were exposed to petasin (0.01-100 micromol/L) to elucidate its vascular effects on isometric contraction elicited by vasoconstrictors, as well as the contribution of the endothelium and Ca(2+) to the responses observed. In addition, L-type voltage-dependent Ca(2+) channel (VDCC) activity and [Ca(2+)](i) were determined in cultured vascular smooth muscle cells (VSMCs) from Sprague-Dawley rats in the presence of 1-100 micromol/L petasin using whole-cell patch-clamp recording and the fluorescent probe fura-2/AM. The effects of petasin on vascular responses were compared between aortic rings from spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats. 3. Petasin reduced isometric contraction elicited by KCl or the L-type Ca(2+) channel opener BayK 8644 (IC(50) 3.0 +/- 0.4 and 4.1 +/- 1.1 micromol/L, respectively) in aortic rings isolated from Sprague-Dawley rats, independent of the endothelium. In addition, petasin triggered a rightward shift in the concentration-response curve to KCl while reducing the maximal response by 82%. In Ca(2+)-depleted and high K(+)-depolarized aortic rings, 1-100 micromol/L petasin pretreatment attenuated the Ca(2+)-induced contraction in a concentration-dependent manner. 4. In cultured VSMCs, whole-cell patch-clamp recording revealed that petasin inhibited VDCC activity. Measurement of [Ca(2+)](i) using fura-2/AM fluorescence indicated that petasin suppressed the KCl-induced increase in [Ca(2+)](i). However, receptor binding assays failed to identify any significant interaction between petasin and the dihydropyridine binding sites of the L-type VDCC. 5. In aortic rings from SHR and WKY rats, petasin inhibited Ca(2+)-induced contractions in Ca(2+)-depleted and high K(+)-depolarized solution with a more pronounced effect in rings from SHR. 6. Together, the results suggest that direct Ca(2+) antagonism of L-type VDCC in vascular smooth muscle may account, at least in part, for petasin-induced vasorelaxation. The more pronounced effect of the sesquiterpene in blood vessels from SHR suggests its possible therapeutic potential in the mangement of hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19719750     DOI: 10.1111/j.1440-1681.2009.05283.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  3 in total

Review 1.  Petasites for Migraine Prevention: New Data on Mode of Action, Pharmacology and Safety. A Narrative Review.

Authors:  Jürgen Borlak; Hans-Christoph Diener; Johanna Kleeberg-Hartmann; Karl Messlinger; Stephen Silberstein
Journal:  Front Neurol       Date:  2022-04-26       Impact factor: 4.086

2.  Therapeutic effects of s-petasin on disease models of asthma and peritonitis.

Authors:  Kyoung-Pil Lee; Saeromi Kang; Min-Soo Noh; Soo-Jin Park; Jung-Min Kim; Hae Young Chung; Nam Kyung Je; Young-Geun Lee; Young-Whan Choi; Dong-Soon Im
Journal:  Biomol Ther (Seoul)       Date:  2015-01-01       Impact factor: 4.634

3.  The contributions of muscarinic receptors and changes in plasma aldosterone levels to the anti-hypertensive effect of Tulbaghia violacea.

Authors:  Ismaila Raji; Pierre Mugabo; Kenechukwu Obikeze
Journal:  BMC Complement Altern Med       Date:  2013-01-11       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.